Enteral Feeding Devices Market is Estimated to Attain $3.58 Billion by 2025

As per the report by Grand View Research, Inc., the Enteral Feeding Devices Market was valued at USD 2.41 billion in 2018 and is estimated to observe a CAGR of 5.8% throughout the forecast period (2019-2025). Increase in occurrence of chronic diseases, such as stroke, dementia, cancer, diabetes, Chronic Obstructive Pulmonary Disease (COPD), multiple sclerosis, and chronic liver disease is anticipated to propel the demand for these products.

Rising aged population, increasing demand in the home care segment, rising incidence of preterm births, and the shift from parenteral to enteral food are the foremost factors propelling the growth of enteral feeding devices in the forecast period. As per Cancer Research U.K., around 17 million new cases of cancer were recorded in 2018 across the globe. Cancer occurrence was anticipated to surge by 62% between 2018 and 2040. The surge in number of cancer cases will lead to increased use of enteral feeding devices thus fueling the demand.

On the other hand, strict government regulations and difficulties associated with enteral feeding devices such as vomiting, nausea, malabsorption, diarrhea, tube clogging, tube malposition, and other may affect the use of this device, thus hindering the market growth.

There are new innovative devices coming up in the market that help overcome these challenges. For instance, Fidmi Medical’s low-profile enteral feeding device removes the need for frequent tube maintenance and replacements of tube patency throughout treatment, thereby decreasing the malfunction risks, reducing hospitalization costs, and allowing satisfactory recovery of patient.

In 2017, Nestle Health Science introduced three new sip feed products under its product line for both children and adult population. The new formula comprises a variety of constituents including proteins, real food, minerals, and vitamins and other ingredients. The product can be given to children and adults through these devices thereby fulfilling the need of daily intake of suggested nutrients.

North America holds the largest share in the global arena over the forecast period due to the growing burden of chronic diseases such as cancer, diabetes, and other neurological conditions. The treatment mostly consists of use of these feeding devices thereby propel their demand in the region.

Leading players operating in the enteral feeding devices market include Abbott Nutrition; CONMED Corporation; Kimberly Clark; Boston Scientific Corporation; Amsino International Inc.; Cook Medical; Danone Medical Nutrition; and Moog Inc.

Access Press Release @ https://www.grandviewresearch.com/press-release/global-enteral-feeding-devices-market

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog:  https://healthcareforecastreport.blogspot.com/

Point of Care (POC) Diagnostics Market Size, Share and Analysis Report

The global Point of Care Diagnostics Market is driven by technological improvements and introduction of sophisticated medical solutions. A host of healthcare establishments are gradually taking to point of care tests and diagnostics solutions for greater efficiency. Growing popularity of EMR (electronic medical record) and PACS (picture archiving and communication systems) has a positive impact on market demand.

Other industry drivers are governmental support, surging healthcare investments, growing geriatric population, and widespread adoption of home based POC devices. When medical diagnostics tests are carried out at the place of patient care, it is known as bedside testing or POCT (point-of-care-testing). New product development is a vital factor that may contribute significantly to market growth during the forecast period (2012 to 2020).

Browse Details of Report @ https://www.hexaresearch.com/research-report/point-of-care-diagnostics-industry

Products, end users, and regions are the parameters based on which the global point of care (POC) diagnostics industry is categorized. As per products, the segments are blood gas/electrolytes, fertility, cardiac markers, OTC & rapid diagnostic tests, infectious diseases, coagulation, drug abuse testing, hospital glucose testing, decentralized clinical chemistry, hematology, and urinalysis. Products also include primary care systems, such as HbA1c tests and lipid profiling. Hospital glucose testing holds the highest market share.

Factors that propel this segment are high incidence of diabetes and the growing necessity for glucose analysis on a regular basis.

The OTC & rapid diagnostic tests market may expand robustly over the forecast period because of the “self diagnosis” trend. People nowadays are highly aware of the importance of early disease diagnosis for on-time & instant disease treatment. Based on end users, the global industry is divided into laboratories, hospitals, clinics, assisted living healthcare facilities, homes, and others. Hospitals & clinics generate highest revenues in the overall market. Diagnostic tests are mostly conducted in clinics and in hospitals. As a result, most of these healthcare centers have begun expanding their POC diagnostic facilities.

Geographically, the worldwide Point Of Care Diagnostics Market is categorized into Asia Pacific, Europe, North America, and Rest of the World (RoW). North America is the largest regional industry. High degree of patient awareness, encouraging government initiatives, and substantial investments in medical infrastructure are prominent regional drivers. It is however, expected that Asia Pacific will register the highest growth rate over the forecast period. This attributes to improvements in healthcare infrastructure in emerging countries, such as India and China.

Companies operating in the global Point Of Care Diagnostics Market continuously strive towards capturing higher market shares. They invest robustly in R&D and product innovations. Prominent market competitors are Trinity Biotech PLC, Danaher Corporation, Siemens Healthcare, Roche Diagnostics, and Becton Dickinson and Company.

In September 2016, Novartis launched the Niji^TM System and Total IgE Test, a POC diagnostic tool. By using just a droplet or two of finer stick blood, this device delivers Immunoglobulin E (IgE) levels in a matter of twelve minutes. This test caters to immediate in-office diagnosis of allergies associated with IgE levels. The availability of such tests in the offices of healthcare providers leads to reduced time for consultation, diagnosis, prognosis, and disease treatment. This in turn leads to better patient outcomes.

Get Sample Copy of this Report @ Point of Care (POC) Diagnostics Market

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - https://www.hexaresearch.com

US Wound Dressing Market Size to Reach USD 4.25 Billion By 2024

12 November 2018 -

The US Wound Dressing Market size is expected to reach USD 4.25 billion by 2024. Growing aging population and cases of diabetes and obesity are the major factors driving the market. Furthermore, increasing incidence of pressure ulcers in bedridden, wheelchair-bound, and/or physically impaired patients is expected to fuel the demand for wound care over the forecast period. For instance, annually, 2.5 million individuals suffer from pressure ulcer in U.S. and around USD 9.1 billion to USD 11.6 billion are spent for its treatment.

Moreover, growing cases of surgical procedures due to high incidence of wound infections and diabetic foot are expected to boost the demand for wound dressing. This has also increased the preference for advanced wound care products over simple dressing. Advanced dressing offers rapid healing, reasonable cost, with minimal inconvenience to the patient. However, owing to the demand for low cost dressing, traditional methods are being used to some extent. This may have a negative impact on the market development over the forecast period.

However, availability of various insurance schemes in U.S. for affordable medical care over long term, coupled with rise in consumer disposable income, is encouraging people to opt for advanced healthcare. This is anticipated to contribute to market expansion over the years to come.

Browse Details of Report @ https://www.hexaresearch.com/research-report/us-wound-dressing-market

The advanced dressing technique is the fastest-growing segment expanding at a CAGR of 4.4% over the forecast period. It also held the dominant market share of USD 1.8 billion in 2017. It is expected to reach USD 2.6 billion by 2024. Advanced dressings includes moist, antimicrobial, and active dressings. Factors such as rapid healing and minimal patient inconvenience are anticipated impel this growth over the forecast period.

Chronic and non-healing wounds are best treated with advanced wound dressing products. Limitations of traditional wound care have propelled the growth of the segment. Advanced moist wound care is recommended for chronic wounds like pressure and diabetic ulcers, burn injuries, and other slow-healing wounds. Advanced foam technique is essential to prevent and heal the exudation of burn injuries. All these factors are projected to propel the growth of the U.S. wound dressing market during the forecast period.

Advanced alginate dressing is recommended in highly exuding wounds, as it forms a gel around the wound bed and helps in keeping them dry and clean. Advanced alginate dressing have gel-forming ability and they also help reduce the pain. As a result, they are widely used for the treatment for bleeding wounds. Advanced films provide healing to semi-dry and dry wounds. Advanced hydrocolloid dressing helps protect the wound internally, as well as externally. Increasing number of surgeries is expected to fuel the growth of hydrogel dressings. All these factors are expected to propel the growth of the wound dressing market over the forecast period.

Antimicrobial dressings are easy to use, accessible without prescription, and less risk of resistant. Silver and non-silver are the two types of this dressings. Silver shows broad spectrum antibacterial activity and minimal toxicity towards host cells. The non-sliver wound dressing may have single or combination of various ingredients, such as iodine, chlorhexidine, Polyhexamethylbuguanide (PHMB), honey, acetic acid, and potassium permanganate. This type of dressing is used for faster healing process and for reducing the pain. Active wound dressings are administered for the repair and healing through bioactive and skin-substitute compounds. They are highly beneficial in healing chronic moist wounds.

Hexa Research has segmented the U.S. wound dressing market report based on product:-

Segmentation by Product Type, 2013 - 2024
    • Traditional
    • Advanced
        • Moist
            • Foam
            • Alginate
            • Films
            • Hydrocolloids
            • Hydrogel
        • Antimicrobial
            • Silver
            • Non-silver
        • Active
            • Biomaterials
            • Skin-substitute

Key Players Analyzed:
    • 3M Healthcare
    • Coloplast
    • Medline Industries
    • HARTMANN.
    • BSN Medical
    • Medtronic Plc
    • Smith & Nephew
    • ConvaTec
    • Derma Sciences
    • Systagenix

 Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website: https://www.hexaresearch.com

Global Healthcare BPO Market is Predicted to Witness High CAGR till 2025

The global Healthcare BPO Market size is expected to witness high growth over the forecast period. Increasing need to reduce operational costs is anticipated drive the market. The business process outsourcing (BPO) model has several advantages such as easy availability of skilled labor, low rates, and reduced training costs. Through outsourcing, medical organizations can concentrate on their core competencies and reduce their efforts and investments on support activities. These factors are driving the adoption of BPO in the medical sector.

High prevalence of various diseases has increased workload of medical institutions. Through adoption of outsourcing solutions, these organizations are able to focus on their core activity to maintain quality of service. Outsourcing services assist organizations in different supporting activities such as accounting, medical transcriptions, and patient database maintenance among others. Collaborations with third party healthcare BPO vendors for these activities is a rising industry trend.

Adoption of business strategies such as alignment of major resources towards core competencies is projected to drive the market over the forecast period. Cost cutting through outsourcing business model is anticipated to further augment the market in near future.

Browse Details of Report @ https://www.hexaresearch.com/research-report/healthcare-bpo-market

Costs of medical services have increased significantly over the last few years. Developing countries such as India, Philippines, and China offer skilled labour at low costs. As a result, companies are able to reduce overall cost by delegating work to vendors located in these regions. This factor is anticipated to positively influence the market over the forecast period. Offshore vendors handle activities such as medical billing, accounting, payroll, medical transcription, and coding.

Hospitals in the U.S. maintain a patient database used by insurance organisations for authentication. Database management and analysis are the key activities requiring professionals with adequate interpretation skills. Staff recruitment for such activities turns out to be a costly affair. Hence, hospitals find it easy to partner up with service providers located at distant locations.

However, risks associated with this business model are major restraints hampering overall growth of the healthcare BPO market. Data security is a growing concern owing to high risk of confidential patient data getting misused. Further, most outsourcing establishments are present in Asia Pacific. This makes coordinating in different time zones a challenge for both parties. Moreover, delays in rendering services on account of these factors are the reason why some organisations prefer in-house activities.

A remarkable rise in adoption of advanced technology in the medical and pharmaceutical sectors is anticipated to boost the growth of the global market for healthcare BPO in the forthcoming years. Hospitals have adopted enterprise resource planning (ERP) systems for crowd control and management. Digitization of various supportive medical activities is poised to bode well for demand in near future.

Moreover, government initiatives to reduce service cost is facilitating the need for outsourcing owing to its cost reduction ability. For instance, in 2012, the U.S Supreme Court upheld the main elements of President’s Patient Protection and Affordable Care Act. As per this act, it is mandatory for all American citizens to buy a health coverage. Further, this act is aimed at expanding medical coverage and providing better care along with reduced wasteful spending. The mandate has forced hospitals to focus on their core functions and cut costs by choosing third party sub-contractors for non-core functions.

Pharmaceutical outsourcing, provider outsourcing, and payers outsourcing are the three major applications of healthcare BPO. Pharmaceutical subcontracting is one of the prominent applications in terms of global demand. Provider subcontracting deals with medical coding, billing, Human Resources (HR), and medical coding. Payers segment deals with handling tasks associated with payroll, finance, and accounts.

North America was the leading region in global market on account of highly developed healthcare sector and high in-house operational costs. Pharmaceutical companies in U.S take support of off-shore vendors to focus on research and development.

Asia Pacific is expected to witness significant growth over the forecast period owing to the overall development of medical science coupled with high prevalence of diseases. In addition, Europe is expected to showcase a steady CAGR in near future mainly on account of developed pharmaceutical sector, especially in France and Germany.

Africa and South America are projected to witness a slow expansion owing to sluggish growth of healthcare industry. Moreover, companies from developing economies prefer in-house activities. This factor is anticipated to hinder regional market growth to an extent. Leading countries where vendors have their operational centers are U.S, Mexico, Ireland, France, India, Philippines, China, Vietnam, South Africa and Argentina.

Key players operating in the healthcare BPO market are Cognizant Technologies; Accenture; Wipro Technologies; Tata Consultancy Services; Genpact; WNS; Hinduja Global; Boehringer Ingelheim; Charles River Laboratories; Covance Inc.; Infosys; Lonza Group; Xerox Corporation; HCL Technologies; Exlservice; Medusind; Catalent; GeBBS Healthcare Solutions; and Quintiles, Inc.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-it-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website: https://www.hexaresearch.com

Kidney Cancer Drugs market is Driven by Changing Lifestyle of the Global Population

The global Kidney Cancer Drugs Market is expected to grow at a healthy rate during the forecast period. Renal Cell Carcinoma (RCC) is one of the most common types of urologic tumors in adults. It accounts for around 2% of all new cases of tumor in humans. However, clinical removal of the cancerous cells is vital for a total cure from the disease. Until last few decades, surgical removal of kidneys. This treatment method was later replaced by laparoscopic removal of tumor-affected area. Medicines are generally prescribed to cure tumors at advanced stage of disease progression.

Early diagnosis is vital when it comes to treatment of this disease. Various treatment methods such as immune modulation therapy, Vascular Endothelial Growth Factor (VEGF) inhibitors, and cytokine therapy are utilized to cure the tumor. Additionally, variety of drugs are available for the treatment of diseases like kidney cancer when identified at an early stage. Hence, governments and healthcare organizations are engaging in awareness drives for early detection. This factor is anticipated to bode well for market over the forecast period.

Prevalence of RCC is projected to increase in near future owing to factors such as rising obesity and number of smokers and reduced physical activities due to changing lifestyle. Symptoms of renal cancer are similar to several other kidney disorders, which make it difficult to get detected. This factor also reduces survival rate among patients who are mostly diagnosed with RCC during routine checkups for some other medical conditions.

Browse Details of Report @ https://www.hexaresearch.com/research-report/kidney-cancer-drugs-market

The global market is majorly driven by changing lifestyle of the global population. Predominance of lifestyle influenced diseases is one of the major driving factors. Excessive smoking and alcohol consumption lead to chronic diseases including different types of cancer. This factor is expected to fuel the market for kidney cancer medicine in the forthcoming years. Rising geriatric population prone to chronic diseases is projected to propel demand for these medicines in the years to come.

Preference for these drugs over targeted remedies is anticipated to bode well for growth of the global market over the forecast period. Also, availability of a limited number of approved drugs is one of the factors assisting product demand. Kidney cancer medicines are one of the life protracting treatment options available for patients suffering from advanced stage of metastatic tumor. Furthermore, occurrence of this disease is expected to be higher in developed countries compared to developing regions. This factor is expected to impel demand for these medicines from regions like North America and Europe.

However, high price of branded drugs is projected to hinder overall growth over the forecast period. As a result, generic medicine variants are preferred over their branded counterparts. This factor is anticipated to obstruct market development in the forthcoming years.
Primary branded medicines in the global kidney cancer drugs market include Nexavar (Sorafenib), Inlyta (Axitinib), Avastin (Bevacizumab), Votrient (Pazopanib), Afinitor (Everolimus), Sutent (Sunitinib), Torisel (Temsirolimus), and Proleukin (Interlukin-2/Aldesleukin). Sutent was one of the highly demanded medicine types in the past. However, drugs like Votrient are also anticipated to witness substantial demand over the forecast period. At present, most potential drugs are in phase II and III clinical trials. Medicines such as Keytruda, AGS-003, Opdivo, Cabozantinib, and Dovitinib are projected to be commercialized and launched in the years to come.

North America accounted for a prominent market share in the past. High prevalence of kidney cancer and other kidney diseases is the primary growth driver. Additionally, U.S. is the largest market for pharmaceuticals. This factor is anticipated to bode well for the growth of the regional demand for kidney cancer drugs. Asia Pacific is estimated to witness significant growth over the forecast period. Lower cost of drug production, high disease prevalence, and rising awareness among healthcare professionals as well as consumers are projected to drive regional growth in the forthcoming years.

The global market is highly consolidated and displays high competition among key participants. Major pharmaceutical giants in the market include Pfizer Inc.; Bayer Pharma AG; GlaxoSmithKline Plc; Hoffman-La Roche; and Novartis AG. Major companies are capitalizing heavily on research and development and adopting strategies like collaborations, new product launches, business expansions, and innovation to uphold their market share.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - https://www.hexaresearch.com

Global Antibiotics Market Size and Share 2025

The global Antibiotics Market is expected to foresee significant growth over the forecast period. An antibiotic is a type of antimicrobial used to treat a number of bacterial infections and to slow down the growth of such infections in the body. The global market for antibiotics is witnessing immense growth due to rising investments in research and development activities along with continuous product innovations by major companies. Rising awareness regarding the advantages of antibiotics, particularly in Asia Pacific, is also likely to drive the market. Companies that accounted for most of this increase were based in regions including China, Brazil, India, Russia, and South Africa.

Product consumption varies significantly in different countries as per demand. Two classes of antibiotic drugs including carbapenems and polymyxins have shown increase in the consumption in past few years and this trend is expected to continue even during the forecast period. Over the past few years, numerous companies have been engaged in product manufacturing and about 79% of the global demand is covered by aminoglycoside. There are various products present in the market such as tetracyclines, penicillin, erythromycin, chloramphenicol, and streptomycin. Factors such as rising demand for effective drugs and increasing prevalence of infectious diseases, especially in emerging economies including Middle East, Africa, Latin America, and Asia Pacific, are significant growth drivers for the market.

Browse Details of Report @ https://www.hexaresearch.com/research-report/antibiotics-market

This trend is expected to continue over the next few years. Rising geriatric population is also anticipated to contribute toward the market expansion in the years to come. The main challenge this industry is facing is emergence of drug resistant strains. As in the category of drugs, antibacterial drugs have various unique characteristics, which make them little less profitable and therefore less attractive investments. These drugs are prescribed for short course of time, anywhere from 4 days to 2 weeks as compared to the medications for cholesterol and anti-hypertensive patients, which last for several years or decades. Innovation in technical development is the key opportunity for the market. Numerous companies in this field are continually investing to develop new, advanced products in order to increase their product portfolio.

Major attention is focused on research and development of vital but less profitable antibacterial drug for the companies to sell at a premium price. The demand for antibiotics is rising particularly to treat children with pneumonia and sepsis. In most countries, 20% of the product is used by healthcare facilities and hospitals while 80% is used by the community. These are either purchased directly by the consumers or are prescribed by the healthcare providers.

Antibiotics can be classified into seven major classes namely phenicols, quinolones, macrolides, sulfonamides, aminoglycosides, tetracyclines, and beta lactams. Around half of the market share was claimed by beta lactams class in the past. The second largest class was quinolones. However, the market will experience a decline as a result of the adverse effects on sales due to patent expiries. However, fluoroquinolones/quinolones is expected to foresee a significant demand in the market over the forecast period as they are used in treating a large number of infections.

Some of the key companies operating in the global market are Pfizer, Inc.; Abbott Laboratories; GlaxoSmithKline PLC; Daiichii Sankyo Company Limited; Bayer HealthCare Pharmaceuticals LLC; Astellas Pharma, Inc.; Merck & Company, Inc.; Roche Holding AG; Bristol-Myers Squibb Co., Cubist Pharmaceuticals, Inc.; GlaxoSmithKline Plc; Pliva d.dd; Toyama Chemica Co. Ltd.; Takeda Pharmaceutical Company. Ltd.; Johnson & Johnson; LG Life Sciences Limited; and Eli Lilly and Co. Pfizer Inc. contributed to the largest share in the past, followed by GlaxoSmithKline PLC and Merck & Company, Inc. With very few patented products available at present, generic manufacturers are leading the global market for antibiotics.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

  

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - https://www.hexaresearch.com

Key Applications of Neurostimulation Devices Market

A recent study by Hexa Research revealed that limited range of treatment choices relating to medical conditions like epilepsy, Alzheimer’s disease, Parkinson’s disease, migraine headaches, etc. is one of the key drivers of the global Neurostimulation Devices Market. An upcoming application area is the use of neurostimulation devices for therapeutic purposes, commonly referred to as neuromodulation. The neurostimulation devices market is benefitting from technological advancements like the transdermal neuromodulation technology by Neurowave Medical Technologies and MRI safety-enabled devices by Medtronics, Inc.

Rising elderly populace - a high risk demographic for Parkinson’s and Alzheimer’s, is also driving market growth. Accelerated demand for neurostimulation devices in the future years is expected to result from untapped market opportunities in emerging economies of Asia as well as Latin America and the growing number of externally funded clinical programs for development of new products.

Browse Details of Report @ https://www.hexaresearch.com/research-report/neurostimulation-devices-industry/

Hexa Research identifies spinal cord stimulation devices, vagus nerve stimulation devices, gastric electric stimulation devices, deep brain stimulation devices, and sacral nerve stimulation devices to be the key product segments in the neurostimulation devices market. Spinal cord stimulation devices, with a contribution of more than half to the total revenues, were the dominant product segment in 2012.

Pain management proved to be the largest application of neurostimulation devices in 2012 and contributed more than 65% to the total demand that year. This was chiefly due to high incidence of conditions characterized by chronic pain and notable therapeutic effects offered by neurostimulation devices.

While North America contributed around 64% to the total revenues in 2012, Asia Pacific is likely to grow the fastest in future. Fast-developing economies like India and China will result in the Asia Pacific neurostimulation devices market growing at CAGR higher than 16% from 2013 to 2020.

Hexa Research observes that the neurostimulation devices industry exhibits outsourcing of expensive manufacturing activities. This enables industry participants to achieve cost efficiency and better profitability. Key industry players include Boston Scientific Corporation, Cyberonics, Medtronic Inc., and St. Jude Medical.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - https://www.hexaresearch.com/

Molecular diagnostic is able to detect cancer at earlier stages

The MolecularDiagnostics Market was valued at over USD 6.40 billion in 2015. It is likely to grow at a CAGR of around 9% during the forecast period (2016-2024).

Increasing prevalence of infectious diseases, cancer, genetic disorders, and other contagious disease are likely to drive the molecular diagnostics industry. Hospital acquired infections and other communicable infections are expected to boost market growth in the coming eight years. Moreover prenatal genetic testing is also expected to increase the adoption of this diagnostics.

Unhealthy lifestyle can further contribute to large number of people getting afflicted with chronic ailments like cardiovascular disorders and diabetes. This with further propel market growth in the coming years. Molecular diagnostics market is divided into products, technologies, applications, test location, and regions.

On the basis of products, the market is split into instruments, reagents, and others. Reagents segment held the largest share in 2015 with revenues exceeding USD 3.5 billion. It is expected to grow at a CAGR surpasing 12%. Instruments segment is expected to show a significant growth in the coming years.

Browse Details of Report @ https://www.hexaresearch.com/research-report/molecular-diagnostics-industry

Technologies consist of polymerase chain reaction (PCR), in-situ hybridization, chips and microarrays, mass spectrometery, DNA sequencing, transportation mediated amplification, and others. PCR held the largest market share of over USD 2.5 billion in 2015. Growth of this segment can be attributed to its high incorporation among the researchers and healthcare professionals. DNA sequencing is likely to show a growth of about 16% CAGR in the coming years.

Applications encompass oncology, pharmacogenomics, infectious diseases, genetic testing, neurological diseases, cardiovascular diseases, and others. Infectious diseases segment was the largest application holding market share exceeding 45% in 2015.

Oncology segment is anticipated to show a CAGR of about 13% till 2024. Rising awareness among people regarding early cancer diagnosis is the key aspect propelling market growth of the segment.

Test location comprises of point of care (PoC), self test or over the counter (OTC), and central laboratories. Central laboratories dominated the market with over 60% shares in 2015. The growth of the central laboratories can be attributed to their large prominence in underdeveloped countries, rising awareness about early detection of diseases, and high procedure volumes.

The PoC is expected to project a lucrative growth with a CAGR of more than 14%. The growth of this segment can be attributed to the increasing demand of bedside patient monitoring and innovative technological devices.

Regions are fragmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa (MEA). America dominated the market with over 40% revenue share. Asia Pacific is likely to exhibit a growth of around 12%CAGR in the coming years.

The key global players of the molecular diagnostics market include Siemens Healthcare GmbH, Novartis AG (Grifols), F. Hoffmann-La Roche Limited, and Johnson & Johnson.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/biotechnology-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - https://www.hexaresearch.com/